Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanaz Jamalzadeh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Iranian Journal of Public Health|July 15, 2015
Prevalence and Pattern of Accessory Teeth (Hyperdontia) in Permanent Dentition of Iranian Orthodontic PatientsFariborz Amini, Vahid Rakhshan, Sanaz Jamalzadeh
Annals of Hematology|September 19, 2025
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013-2022 in FinlandJuha Ranti, Sanaz Jamalzadeh, Eleonora Mäkelä, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
BMC Cancer|February 5, 2024
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinomaSanaz Jamalzadeh, Jun Dai, Kari Lavikka, et al.
Science Advances|February 23, 2022
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancerKaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh, et al.
Cancer Cell|May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinomaAlexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Nature Communications|June 24, 2021
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistanceElina A Pietilä, Jordi Gonzalez-Molina, Lidia Moyano-Galceran, et al.
Cell Reports. Medicine|August 30, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancerDaria Afenteva, Rong Yu, Anna Rajavuori, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Iranian Journal of Public Health|July 15, 2015
Prevalence and Pattern of Accessory Teeth (Hyperdontia) in Permanent Dentition of Iranian Orthodontic PatientsFariborz Amini, Vahid Rakhshan, Sanaz Jamalzadeh
Annals of Hematology|September 19, 2025
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013-2022 in FinlandJuha Ranti, Sanaz Jamalzadeh, Eleonora Mäkelä, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
BMC Cancer|February 5, 2024
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinomaSanaz Jamalzadeh, Jun Dai, Kari Lavikka, et al.
Science Advances|February 23, 2022
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancerKaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh, et al.
Cancer Cell|May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinomaAlexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Nature Communications|June 24, 2021
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistanceElina A Pietilä, Jordi Gonzalez-Molina, Lidia Moyano-Galceran, et al.
Cell Reports. Medicine|August 30, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancerDaria Afenteva, Rong Yu, Anna Rajavuori, et al.
Pageof 1